These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study. Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034 [TBL] [Abstract][Full Text] [Related]
11. Endovascular therapy for vasospasm after aneurysmatic subarachnoid hemorrhage. Kerz T; Boor S; Ulrich A; Beyer C; Hechtner M; Mueller-Forell W Br J Neurosurg; 2016 Oct; 30(5):549-53. PubMed ID: 27080311 [TBL] [Abstract][Full Text] [Related]
12. Continuous intra-arterial infusion of nimodipine at the onset of resistant vasospasm in aneurysmal subarachnoidal haemorrhage. Technical report. Doukas A; Petridis AK; Barth H; Jansen O; Mehdorn HM Neurol Res; 2011 Apr; 33(3):290-4. PubMed ID: 20626962 [TBL] [Abstract][Full Text] [Related]
13. Intraarterial nimodipine for the treatment of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a preliminary study. Dehdashti AR; Binaghi S; Uske A; Regli L Neurol India; 2011; 59(6):810-6. PubMed ID: 22234190 [TBL] [Abstract][Full Text] [Related]
14. Continuous intra-arterial nimodipine for the treatment of cerebral vasospasm. Mayer TE; Dichgans M; Straube A; Birnbaum T; Müller-Schunk S; Hamann GF; Schulte-Altedorneburg G Cardiovasc Intervent Radiol; 2008; 31(6):1200-4. PubMed ID: 18446409 [TBL] [Abstract][Full Text] [Related]
15. Side effects of continuous intra-arterial infusion of nimodipine for management of resistant cerebral vasospasm in subarachnoid hemorrhage patients: A systematic review. Viderman D; Sarria-Santamera A; Bilotta F Neurochirurgie; 2021 Sep; 67(5):461-469. PubMed ID: 33652066 [TBL] [Abstract][Full Text] [Related]
16. Clinical Course and Monitoring Parameters After Continuous Interventional Intra-Arterial Treatment in Patients with Refractory Cerebral Vasospasm. von der Brelie C; Doukas A; Stopfer A; Larsen N; Mehdorn M; Synowitz M; Jansen O World Neurosurg; 2017 Apr; 100():504-513. PubMed ID: 28131927 [TBL] [Abstract][Full Text] [Related]
17. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm. Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257 [TBL] [Abstract][Full Text] [Related]
18. Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children. Heffren J; McIntosh AM; Reiter PD Pediatr Neurol; 2015 Mar; 52(3):356-60. PubMed ID: 25585913 [TBL] [Abstract][Full Text] [Related]
19. Side Effects of Long-Term Continuous Intra-arterial Nimodipine Infusion in Patients with Severe Refractory Cerebral Vasospasm after Subarachnoid Hemorrhage. Kieninger M; Flessa J; Lindenberg N; Bele S; Redel A; Schneiker A; Schuierer G; Wendl C; Graf B; Silbereisen V Neurocrit Care; 2018 Feb; 28(1):65-76. PubMed ID: 28685393 [TBL] [Abstract][Full Text] [Related]
20. The Impact of Intra-Arterial Papaverine-Hydrochloride on Cerebral Metabolism and Oxygenation for Treatment of Delayed-Onset Post-Subarachnoid Hemorrhage Vasospasm. Hosmann A; Wang WT; Dodier P; Bavinzski G; Engel A; Herta J; Plöchl W; Reinprecht A; Gruber A Neurosurgery; 2020 Sep; 87(4):712-719. PubMed ID: 31792510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]